What is MobileODT?
Founded in 2012 and headquartered in Tel Aviv, Israel, MobileODT is at the forefront of developing innovative AI colposcopy and visual assessment solutions. These technologies are designed to empower women's health clinicians with advanced tools for more accurate and efficient diagnoses. By leveraging artificial intelligence, MobileODT aims to improve early detection rates for critical conditions, thereby enhancing patient outcomes and streamlining clinical workflows. The company's commitment to integrating cutting-edge technology into women's healthcare positions it as a key player in the digital health and medtech industries.
How much funding has MobileODT raised?
MobileODT has raised a total of $10.8M across 2 funding rounds:
Series B
$6.8M
Series C
$4M
Series B (2017): $6.9M with participation from Tristel and OrbiMed Advisors LLC
Series C (2020): $4M led by Tristel, Tara Health, Laerdal, and OrbiMed Israel Partners
Key Investors in MobileODT
Tristel
Tristel is a company involved in the funding round, likely providing strategic capital or expertise relevant to the healthcare or technology sectors.
OrbiMed Israel Partners
OrbiMed Israel Partners is a venture capital firm specializing in the healthcare and life sciences sectors, known for investing in companies developing innovative medical technologies and therapies.
Tara Health
Tara Health is an investor participating in the funding round, likely focused on healthcare or impact investments.
What's next for MobileODT?
With the recent infusion of major strategic capital, MobileODT is poised for significant expansion and further technological development. The company is likely to focus on scaling its operations, enhancing its AI algorithms, and broadening the adoption of its solutions globally. This strategic investment signals strong confidence from backers in MobileODT's potential to revolutionize women's health diagnostics. Future initiatives may include expanding its product portfolio, forging new clinical partnerships, and penetrating new geographic markets, solidifying its position as a leader in AI-powered medical imaging and assessment.
See full MobileODT company page
